This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahn, E.-Y. Articles by McDonald, J. M. Search for Related Content PubMed PubMed Citation Articles by Ahn, E.-Y. Articles by McDonald, J. M.

(American Journal of Pathology. 2003;163:2053-2063.)
© 2003 American Society for Investigative Pathology

The Combination of Calmodulin Antagonists and Interferon- Induces Apoptosis through Caspase-Dependent and -Independent Pathways in Cholangiocarcinoma Cells

Eun-Young Ahn^*, George Pan^*, Jae Hwan Oh^*, Ewan M. Tytler and Jay M. McDonald^*

From the Departments of Pathology^* and Surgery, The University of Alabama at Birmingham, Birmingham; and The Veterans Administration Medical Center, Birmingham, Alabama

Calmodulin (CaM) antagonists have been shown to inhibit tumor cell invasion and metastasis and to induce apoptosis in various tumor models, but the molecular mechanism of CaM antagonist-mediated apoptosis is poorly understood. Here, we demonstrate that interferon (IFN)- induces susceptibility to CaM antagonist-mediated apoptosis in human cholangiocarcinoma cells weakly expressing Fas (Fas-low cells). During CaM antagonist-mediated apoptosis in IFN--pretreated Fas-low cells, cleavage of caspases-8, -9, and -3 and Bid, release of cytochrome c from the mitochondria and an increase in the free cytosolic calcium concentration were observed. CaM antagonists also caused depolarization of the mitochondrial membrane independent of caspase activation. Although a broad-range caspase inhibitor partially blocked CaM antagonist-mediated apoptosis, the neutralizing Fas antibody had no effect, suggesting that CaM antagonist-mediated apoptosis does not require interaction between CaM antagonists and surface Fas. CaM antagonists induce apoptosis via mechanisms other than inhibition of CaM-dependent protein kinase II and calcineurin, as their inhibitors, KN93 and cyclosporine A, had no effect on apoptosis. Taken together, these results indicate that CaM antagonists induce apoptosis in both caspase-dependent and -independent manners, and that susceptibility to CaM antagonists is modulated by IFN-. The combination of IFN- and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.

This article has been cited by other articles:

				V. J. HASSID, F. A. ORLANDO, Z. T. AWAD, D. TAN, T. KHOURY, B. H. AHMED, and S. J. ALRAWI Genetic and Molecular Abnormalities in Cholangiocarcinogenesis Anticancer Res, April 1, 2009; 29(4): 1151 - 1156. [Abstract] [Full Text] [PDF]

				P. Pawar, L. Ma, C. H. Byon, H. Liu, E.-Y. Ahn, N. Jhala, J. P. Arnoletti, J. M. McDonald, and Y. Chen Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin Clin. Cancer Res., February 15, 2009; 15(4): 1288 - 1296. [Abstract] [Full Text] [PDF]

				X. Wu, E.-Y. Ahn, M. A. McKenna, H. Yeo, and J. M. McDonald Fas Binding to Calmodulin Regulates Apoptosis in Osteoclasts J. Biol. Chem., August 19, 2005; 280(33): 29964 - 29970. [Abstract] [Full Text] [PDF]

				D. Boehning, D. B. van Rossum, R. L. Patterson, and S. H. Snyder A peptide inhibitor of cytochrome c/inositol 1,4,5-trisphosphate receptor binding blocks intrinsic and extrinsic cell death pathways PNAS, February 1, 2005; 102(5): 1466 - 1471. [Abstract] [Full Text] [PDF]

				E.-Y. Ahn, S.-T. Lim, W. J. Cook, and J. M. McDonald Calmodulin Binding to the Fas Death Domain: REGULATION BY FAS ACTIVATION J. Biol. Chem., February 13, 2004; 279(7): 5661 - 5666. [Abstract] [Full Text] [PDF]